Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group. [electronic resource]
Producer: 20120813Description: 3631-3 p. digitalISSN:- 1524-4628
- Adult
- Aged
- Blood Coagulation -- drug effects
- Cerebral Hemorrhage -- drug therapy
- Cerebral Ventricles -- drug effects
- Dose-Response Relationship, Drug
- Female
- Fibrinogen -- metabolism
- Humans
- Injections, Intraventricular
- Male
- Middle Aged
- Platelet Count
- Retrospective Studies
- Thrombolytic Therapy
- Tissue Plasminogen Activator -- administration & dosage
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.